Leap Therapeutics has filed a notice of an exempt offering of securities to raise $77,219,193.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Leap Therapeutics is raising $77,219,193.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Douglas Onsi played a…